Trials / Completed
CompletedNCT00786773
Survey to Describe Impact of Reflux Disease on Everyday Life in GERD Patients Before and After 4 Weeks Treatment.
Epidemiological Survey to Describe Impact of Reflux Disease on Everyday Life in GERD Patients Before and After 4 Weeks Treatment
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 2,091 (actual)
- Sponsor
- AstraZeneca · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To describe the change of impact of reflux symptoms on the everyday life perceived by patients before and after 4 weeks treatment by using GERD Impact Scale questionnaire (GIS) by total GERD patient population and by treatment group; and to describe the concordance between patient-reported and physician-reported symptom load.
Conditions
Timeline
- Start date
- 2008-10-01
- Completion
- 2009-06-01
- First posted
- 2008-11-06
- Last updated
- 2010-12-07
Locations
18 sites across 1 country: Vietnam
Source: ClinicalTrials.gov record NCT00786773. Inclusion in this directory is not an endorsement.